Copyright
©The Author(s) 2025.
World J Hepatol. Mar 27, 2025; 17(3): 104520
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.104520
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.104520
Figure 4 Mogroside V inhibits acetaminophen-induced c-jun-N-terminal kinase activation in the liver of acetaminophen-treated mice.
Mice were pretreated with or without Mogroside V for one hour prior to acetaminophen administration, and the protein level of phosphorylated c-jun-N-terminal kinase (JNK) and total JNK were measured six hours later. n = 3-5 per group. aP < 0.05, bP < 0.01. MV: Mogroside V; APAP: Acetaminophen; GSH: Glutathione.
- Citation: Shi JL, Sun T, Li Q, Li CM, Jin JF, Zhang C. Mogroside V protects against acetaminophen-induced liver injury by reducing reactive oxygen species and c-jun-N-terminal kinase activation in mice. World J Hepatol 2025; 17(3): 104520
- URL: https://www.wjgnet.com/1948-5182/full/v17/i3/104520.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i3.104520